Calyxt (NASDAQ:CLXT) – Jefferies Group decreased their Q1 2018 earnings per share (EPS) estimates for shares of Calyxt in a research note issued to investors on Thursday. Jefferies Group analyst A. Jagdale now forecasts that the company will earn ($0.31) per share for the quarter, down from their prior forecast of ($0.26). Jefferies Group currently has a “Buy” rating and a $27.00 price target on the stock. Jefferies Group also issued estimates for Calyxt’s Q2 2018 earnings at ($0.32) EPS, Q3 2018 earnings at ($0.37) EPS, Q4 2018 earnings at ($0.41) EPS, FY2018 earnings at ($1.41) EPS, Q1 2019 earnings at ($0.31) EPS, Q2 2019 earnings at ($0.31) EPS, Q3 2019 earnings at ($0.36) EPS, Q4 2019 earnings at ($0.42) EPS, FY2019 earnings at ($1.40) EPS, FY2020 earnings at ($1.14) EPS and FY2021 earnings at ($0.62) EPS.
A number of other analysts have also recently issued reports on CLXT. Zacks Investment Research raised Calyxt from a “sell” rating to a “hold” rating in a research report on Tuesday, November 28th. Ladenburg Thalmann Financial Services started coverage on Calyxt in a research report on Wednesday, December 20th. They issued a “buy” rating and a $34.25 target price for the company. Finally, ValuEngine cut Calyxt from a “hold” rating to a “sell” rating in a research report on Wednesday, March 7th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $29.05.
In other Calyxt news, Director Alain Godard sold 19,825 shares of the stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $19.65, for a total transaction of $389,561.25. Following the completion of the sale, the director now directly owns 45,325 shares of the company’s stock, valued at approximately $890,636.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Manoj Sahoo sold 10,780 shares of the stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $19.87, for a total value of $214,198.60. Following the sale, the insider now directly owns 95,146 shares of the company’s stock, valued at $1,890,551.02. The disclosure for this sale can be found here. Insiders have sold a total of 104,496 shares of company stock valued at $2,045,928 over the last ninety days.
A number of institutional investors have recently bought and sold shares of CLXT. Bank of New York Mellon Corp acquired a new stake in Calyxt during the 3rd quarter worth approximately $542,000. American International Group Inc. purchased a new position in shares of Calyxt during the 3rd quarter worth approximately $133,000. Schwab Charles Investment Management Inc. purchased a new position in shares of Calyxt during the 3rd quarter worth approximately $358,000. California State Teachers Retirement System purchased a new position in shares of Calyxt during the 3rd quarter worth approximately $323,000. Finally, Wells Fargo & Company MN raised its stake in shares of Calyxt by 1,421.9% during the 4th quarter. Wells Fargo & Company MN now owns 30,788 shares of the company’s stock worth $678,000 after buying an additional 28,765 shares in the last quarter. 22.35% of the stock is owned by institutional investors.
ILLEGAL ACTIVITY NOTICE: “Calyxt (CLXT) Expected to Earn Q1 2018 Earnings of ($0.31) Per Share” was originally reported by Ticker Report and is owned by of Ticker Report. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3300644/calyxt-clxt-expected-to-earn-q1-2018-earnings-of-0-31-per-share.html.
Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, enhanced oil composition and herbicide tolerant canola, enhanced quality and herbicide tolerant alfalfa, late blight resistant potatoes, and cold storable/reduced browning potatoes, as well as enhanced protein composition, drought tolerant, herbicide tolerant, and enhanced yield soybeans.
Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.